← Back to Search

Dietary Supplement for Obesity

N/A
Waitlist Available
Led By Veena K Ranganath, M.D., M.S.
Research Sponsored by Dr. Veena Ranganath
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 6 and 12 months
Awards & highlights

Study Summary

This study is evaluating whether a weight loss intervention will improve your rheumatoid arthritis disease activity.

Eligible Conditions
  • Obesity
  • Rheumatoid Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in DAS28
change in PDUS
Secondary outcome measures
MBDA

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Dietary SupplementExperimental Treatment2 Interventions
Group II: Dietary CounselingActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Whey Protein&Prebiotic Supplement
2016
N/A
~40
Dietary recommendations
2019
N/A
~150

Find a Location

Who is running the clinical trial?

Dr. Veena RanganathLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
Veena Ranganath, MD, MSLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
Veena K Ranganath, M.D., M.S.Principal InvestigatorUniversity of California, Los Angeles
1 Previous Clinical Trials
40 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025